Cancer Focus Fund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
10
- Investments
-
12
- Portfolio
-
7
- Exits
-
2
Cancer Focus Fund General Information
Company Description
Founded in 2019, Cancer Focus Fund is a venture capital firm based in Houston, Texas and Shreveport, Louisiana. The firm seeks to invest in promising therapies in late preclinical development through Phase I and Phase Ib/II clinical trials. The firm's objective is to provide support to accelerate the development of these therapeutics together with the clinical trials expertise and infrastructure of The University of Texas MD Anderson Cancer Center.
Business Details
Website
www.cancerfocusfund.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 7255 Helix Park Avenue
- Suite 300
- Houston, TX 77030
- United States
Cancer Focus Fund Investments (12)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Link Cell Therapies | 28-Sep-2026 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Starget Pharma | 18-Feb-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| KAHR Bio | 01-Sep-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| March Biosciences | 03-Jan-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Starget Pharma | 28-Oct-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| ImmunoGenesis | 02-Apr-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Eisbach | 21-Mar-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| March Biosciences | 09-Nov-2023 | Drug Discovery | Clinical Trials - Phase 2 | |||
| ISA Pharmaceuticals | 15-Dec-2022 | Later Stage VC | Drug Discovery | Bankruptcy: Liquidation | ||
| Nectin Therapeutics | 23-Feb-2022 | Later Stage VC | Biotechnology | Pre-Clinical Trials |
Cancer Focus Fund Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| ISA Pharmaceuticals | 18-Jul-2024 | Bankruptcy: Liquidation | |
| Mereo Biopharma Group | 17-Jun-2024 |
Cancer Focus Fund Investments by Industry, Year, and Region
Cancer Focus Fund Co-Investors (48)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Peregrine Ventures | 2 |
|
|
||
| aMoon Fund |
|
|
|||
| Johnson & Johnson JJDC |
|
|
|||
| Magnetar Capital |
|
|
|||
| Western Technology Investment |
|
|
Cancer Focus Fund FAQs
-
What is Cancer Focus Fund?
Founded in 2019, Cancer Focus Fund is a venture capital firm based in Houston, Texas and Shreveport, Louisiana.
-
When was Cancer Focus Fund founded?
Cancer Focus Fund was founded in 2019.
-
Where is Cancer Focus Fund headquartered?
Cancer Focus Fund is headquartered in Houston, TX.
-
What is Cancer Focus Fund's total asset value?
Cancer Focus Fund has around in total assets under management.
-
How many investments has Cancer Focus Fund made?
Cancer Focus Fund has made 12 investments.
-
What has Cancer Focus Fund invested in?
Cancer Focus Fund has made numerous investments in companies like Link Cell Therapies, Starget Pharma, and KAHR Bio within the Drug Discovery industry.
-
What has Cancer Focus Fund invested in recently?
Cancer Focus Fund's latest investment was on 28-Sep-2026 in Link Cell Therapies, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process